Toward a vaccine to prevent toxoplasmosis

Grants and Contracts Details


Work with HF10, Balb/C, SAG 1 and other epiotopes, IL 12 and alum and later with GRA2 and with type 1 parasites and in later years with hypervirulent recombinant parasites and survival studies. In later years with T cell studies and T cell transfer studies
Effective start/end date7/1/116/30/12


  • The University of Chicago: $103,600.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.